Buying a Med Spa
A growth category where the ownership rules come first: many states restrict who can own medical services, injector relationships carry the revenue, and compliance is the diligence landmine. How med spas trade and what actually transfers in a sale.
First, the Ownership Rule
Med spas deliver medical services (injectables, laser treatments, IV therapy), and many states apply corporate-practice-of-medicine doctrines that restrict non-physician ownership of medical practices. Buyers in those states typically use a management services organization structure: a physician-owned entity holds the clinical practice while your company owns the brand, systems, and operations under a management agreement. This is settled practice, but it is state-specific lawyering, and it belongs at the start of your process, not the end. Several states also tightened scrutiny of supervision and MSO structures through 2025.
What Med Spas Trade For
2025 market coverage puts smaller med spas (under about $4M revenue) at roughly 3x to 6x EBITDA, mid-sized groups at 5x to 8x, and regional platforms above that, with premium pricing reported for practices holding membership revenue above roughly 30% of total. Consolidators are active across the category, which supports exits and inflates seller expectations at searcher size in equal measure. Anchor on the small-practice band, not platform headlines.
The Injectors Are the Revenue
Aesthetic patients follow their injector more than the brand, and a practice's production usually concentrates in a few nurse injectors or the selling owner. Underwrite them like the asset they are: production by provider, tenure, compensation against a competitive hiring market, non-solicitation coverage, and whether the seller personally injects a large share of revenue. A med spa where the departing owner is also the star injector is a very different deal from one with an employed, retained clinical team.
Membership Turns Visits Into Revenue Quality
The category's best operators converted episodic treatments into monthly memberships and packages, and 2025 coverage treats a membership base around a third of revenue as a meaningful premium driver. Memberships smooth the demand curve, fund inventory, and make retention measurable. In diligence, read the membership terms honestly: churn, banked-but-unredeemed treatment liabilities, and whether deferred obligations are carried on the books or waiting to surprise you.
What to Verify in Diligence
Compliance first, because it can kill the deal overnight: the medical director agreement's substance (not just its signature), scope-of-practice and supervision protocols for every service on the menu, adverse-event documentation, and controlled-inventory handling for prescription products. Then the commercial layer: revenue by service line and provider, patient retention and cohort behavior, discounting habits, review profile, equipment leases on lasers and devices (often surprisingly large), and any franchise or brand obligations.
Financeability Notes
Med spa acquisitions finance under SBA 7(a) where the structure satisfies state ownership rules, and lenders increasingly know the MSO pattern; expect legal-structure review in underwriting alongside the usual earnings questions. Provider retention agreements materially help the file. Model debt service on earnings net of a replacement medical director's cost and the marketing spend the category actually requires, which sellers routinely understate in add-backs.
What the Data Says
2025 market coverage places smaller med spas (under about $4M revenue) at roughly 3x to 6x EBITDA and mid-sized groups at 5x to 8x, with platform-scale deals above those bands; directional ranges, not comps for any specific practice.
Corporate-practice-of-medicine rules in many states restrict non-physician ownership of medical services, making management-services-organization structures the standard buyer path, with 2025 coverage noting increased scrutiny of supervision, scope of practice, and MSO arrangements in several states.
Membership and recurring-revenue share is a reported premium driver, with practices holding memberships above roughly 30% of revenue valued meaningfully ahead of otherwise identical practices.
Compare bands across industries in the Industry Multiple Benchmarks.
Where to Go Next
Get New Guides by Email
More industries are in research. Leave your email to receive each guide as it publishes.